Latest News
Browne Jacobson’s private equity team has advised independent private equity and infrastructure investment manager Foresight Group (Foresight) on its exit from e-commerce fulfilment specialist, Selazar Limited (Selazar), generating a 3.4x return for the Midland Engine Investment Fund (MEIF) managed by Foresight after less than two years.
The Browne Jacobson team was led by Midlands-based associate Matt Bolton, who also advised Foresight on MEIF’s initial and follow-on investments in Selazar in 2019 and 2020 (respectively), supported by Birmingham-based private equity partner, Gareth Davies.
The exit is the first for MEIF, which was launched by the UK Government-owned British Business Bank (BBB)
Suzanne Beckett from Blick Rothenberg’s Financial Services team takes an in-depth look at partial exemption special methods and the benefits available to private equity firms.
British Patient Capital has made a EUR25 million commitment to the Nauta Tech Invest V Fund, as Nauta Capital announces its final close at EUR190 million.
Investing from late seed and Series A, the fund has already invested in 11 companies in verticals including Fintech, Insurtech, Retailtech, and Open Source, among others.
Nauta Capital specialises in capital-efficient early-stage B2B software companies. The firm’s main areas of interest include SaaS solutions with strong network effects, vertically focused enterprise tech with the potential to transform large industries as well as those leveraging deeptech applications to solve challenges faced by large enterprises.
Aura Biosciences, a portfolio company of Spanish biotechnology venture capital firm Ysios Capital, has priced its initial public offering (IPO) and is trading on the Nasdaq Global Market (NASDAQ: AURA).
Dr Louise Rix, a former VC at Forward Partners, is stepping into the start-up world and taking up a new role as Chief Medical Officer at femtech start-up Béa Fertility.
Co-founded by femtech expert Tess Cosad, embryologist David O’Rourke and product engineer George Thomas, Béa Fertility is developing clinical-grade, at-home fertility treatments for people who are struggling to conceive naturally. The startup raised USD1 million in pre-seed funding earlier this year to expand their team and bring their pioneering fertility solution to market. The round was led by Calm/Storm VC and joined by Q Ventures.
As Chief Medical Officer,
Global investment firm Carlyle has acquired a majority stake in CSS AG (CSS), a German business software provider with a focus on accounting, controlling and human resources (HR) software. Majority shareholder Michael Friemel will retain a large minority stake in CSS and will continue to lead the company as CEO.
Founded in 1984, CSS is headquartered in Künzell, Germany, and serves and supports its customers from eight additional regional offices. CSS is the only vendor with a fully integrated all-in-one business solution, named eGECKO, for accounting, controlling and HR modules which is specifically targeted at the needs of local and
BC Partners is to acquire a controlling stake in Pet City, pet retailer in Greece. Specific terms of the transaction have not been disclosed.
The deal represents the first investment of BC Partners GR Investment LP (BCPGR), a special purpose fund which seeks to invest in and support high-growth small and medium-sized companies in Greece. This transaction and BCPGR is a testament to BC Partners’ unique deep regional network across Europe.
Pet City was founded in 1988 and has grown as a family-owned business to be the clear market leader in Greece serving around 3 million customers. The founding
Sir Paul Marshall has today announced a GBP50 million donation to the London School of Economics’ (LSE) Marshall Institute, which will kick-start a unique accelerator for social impact ventures, as part of his long-term ambition to create a philanthropic cooperative that brings together capital, expertise and passion for change in one place.
The Marshall Impact Accelerator will provide a brand new platform for the world’s most promising social ventures, scaling them to help us tackle global challenges in areas such as health, the environment, social inequality, public policy and developmental economics.
Bringing together LSE’s world-leading research expertise and the Marshall
Amadeus Capital Partners has expanded its deep tech investment team with the appointment of Dr Manjari Chandran-Ramesh as a Partner in its Early Stage Team.
Chandran-Ramesh will focus on investing in start-ups and spinouts centring on machine learning and quantum technologies, in the Oxford innovation cluster and other university centres throughout the UK.
Chandran-Ramesh joins with more than a decade of experience in commercialising university intellectual property (IP) and a PhD in Machine Learning and Autonomous Vehicles, completed at the University of Oxford as a Rhodes Scholar. Chandran-Ramesh has expertise in sourcing high-growth companies, helping founders to build a
iCapital Network has added to its private investments offering with the launch of the AMG Pantheon Fund, LLC, BlackRock Private Investments Fund, Carlyle Tactical Private Credit Fund, and Hamilton Lane Private Assets Fund on its platform.
The expansion of iCapital’s fund offerings suitable for accredited investors and qualified clients enables financial advisors and their clients to access the return and diversification potential offered by private market investments with accessible investment minimums and simplified operations.
During the past 12 months, iCapital has prioritised expanding the selection of registered funds and other vehicles for accredited investors available on its flagship platform. These
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
